I offloaded the majority of my parcel on the Jansen results due to very little information provided regarding the path to commercialisation. To be honest I was expecting Jansen to licence PromarkerD. I don't understand why they wouldn't do so, if the test does what it says it does. I'm not very well versed in this technology, so to my (perhaps untrained) eye it was underwhelming and threw a lot of doubt in my mind. I recently offloaded the remainder of my holdings (prior to the Italian deal) since nothing appeared to be happening, and i got frustrated with the lack of progress regarding FDA approval.
I think for me, since I am not very well versed on this technology, I will wait for cash flow before re-entering as proof that the test is useful/works/in demand and can provide profits to the company.
At the moment with the information the company has provided I cannot forecast when cash flows from PromarkerD will occur.
Cheers and goodluck all.
I'll be around the traps watching.
PIQ Price at posting:
56.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)